Oxford Biomedica Plc (OXBL)

943.50p
   
  • Change Today:
      41.50p
  • 52 Week High: 954.50
  • 52 Week Low: 235.50
  • Currency: UK Pounds
  • Volume: 4,678

OXBL Overview

Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.

Key Personnel

CEO: Frank Mathias
CFO: Lucinda (Lucy) Crabtree
Chairman: Roch Doliveux
Independent Non-Executive Director: Namrata P Patel
Independent Non-Executive Director: Heather Preston
Senior Independent Director: Dame Kay Davies
Non-Executive Dir: Laurence Espinasse, Colin Bond , Peter Soelkner

Contact Details

Address: Windrush Court, Transport Way, Oxford, United Kingdom, OX4 6LT
Phone: +44 (0) 1865 783 000
Fax: +44 (0) 1865 783 001
Website: http://www.oxb.com/

Listings

Overseas Listings: LSE:OXB
ISIN: GB0006648157

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

 

OXBL Market Data

Currency UK Pounds
Share Price 943.50p
Change Today 41.50p
% Change 4.60 %
52 Week High 954.50
52 Week Low 235.50
Volume 4,678

Trades for 16-Jan-2026

Time Volume / Share Price
09:35 166 @ 943.00p
09:35 162 @ 943.00p
09:35 37 @ 942.00p
09:35 1,064 @ 936.50p
09:34 60 @ 933.00p

OXBL Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page